Stipe Therapeutics

Stipe Therapeutics

STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting intracellular protein-protein interactions of the STING Pathway; a major driver of innate immunity, and regul
Aarhus Denmark (HQ)

Stipe Therapeutics Company information

Edit
Ownership
Firm valuation
€80—120m (Dealroom.co estimates Sep 2019.)
  • Edit
DateInvestorsAmountRound
€20mSERIES A
Total Funding€20m

Recent News about Stipe Therapeutics

Edit
LocationEdit
Lyngsiesvej 18, 8230 Aarhus, Denmark
Are you an employee or an investor of this company?
Add your profile